Communications of the ACM
Artificial Intelligence Is Booming, but Can the FDA Keep Up?
The use of artificial intelligence in medicine is accelerating rapidly. The U.S. Food and Drug Administration has approved three products this year that use AI to help diagnose health problems, including one OK'd late last month that detects wrist fractures. And some companies, like IBM, have put their products on the market without the agency's sign-off.
The technology is evolving so quickly that experts fear the FDA, which is still trying to develop a process for regulating artificial intelligence—seven years after it began the effort, in some product categories—won't be able to keep up. They say the agency can't compete with private-sector salaries to attract people with the necessary AI knowledge to evaluate the benefits and dangers these algorithms pose.
From STAT
View Full Article
No entries found